Aletha Maybank, MD, MPH recently joined the AMA in April 2019 as their inaugural Chief Health Equity Officer and Vice President. Her role is to embed health equity in all the work of the AMA and to launch a Center for Health Equity.
Prior to this in 2014, Dr. Maybank became an Associate Commissioner, and later a Deputy Commissioner, and lunched the Center for Health Equity, a new division in the NYC Department of Health and Mental Hygiene geared toward strengthening and amplifying the Health Department’s work in ending health inequities. Under her leadership, and in a short amount of time, the health department made great strides in transforming the culture and public health practice by embedding health equity in the health department’s work. This work has been recognized and adapted by other City agencies and has captured the attention of the CDC and WHO.
She also teaches medical and public health students on topics related to health inequities, public health leadership and management, physician advocacy, and community organizing health. Currently, Dr. Maybank serves as President of the Empire State Medical Association, the NYS affiliate of the National Medical Association. In 2012, she co-founded “We Are Doc McStuffins,” a movement created by African-American female physicians who are inspired by the Disney Junior character, Doc McStuffins.
Dr. Maybank holds a BA from Johns Hopkins University, an MD from Temple University School of Medicine, and an MPH from Columbia University Mailman School of Public Health. She is a pediatrician and board certified in Preventive Medicine and Public Health.
Lunch Plenary:
A Commitment to Advance Health Equity
Eighteen Blue Cross Blue Shield Plans Join Civica Rx to Lower Generic Drug Costs
/in Policy California Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyTwo weeks after California’s governor announced plans to produce generic drugs, 18 national Blue Cross Blue Shield plans said they will join with the non-profit Civica Rx to produce lower-cost generic drugs. As summarized in the National Academy for State Health Policy’s Jan. 13, 2020, blog Can States Really Produce Generic Drugs? The Civica Rx […]
Connecticut Governor Sets Health Care Cost and Quality Benchmarks
/in Policy Connecticut Blogs, Featured News Home Health System Costs, Total Cost of Care Benchmark /by Chris KukkaLast week, Gov. Ned Lamont signed two executive orders that establish health care cost growth and quality benchmarks and require more transparency of Medicaid costs and quality. The benchmarks are similar to ones Massachusetts implemented, which has helped Bay State consumers avoid more than $5 billion in costs since 2013. “Gov. Lamont’s initiative directly addresses the high costs of health care […]
New Federal Rule Increases Administrative Burdens and Cost to Marketplaces
/in Policy Blogs, Featured News Home Health Coverage and Access, State Insurance Marketplaces /by Christina CousartNew regulations imposed by the US Department of Health and Human Services (HHS) require a significant change in how insurers bill consumers for health insurance premiums. The technical change: Imposes a significant administrative burden on insurers, the health insurance marketplaces, and consumers; Raises premium prices; and Risks generating confusion among consumers when they pay their […]
Transforming Systems to Improve Health Upstream: Lessons from Washington’s Accountable Communities of Health
/in Policy Washington Blogs, Featured News Home Behavioral/Mental Health and SUD, Chronic and Complex Populations, Chronic Disease Prevention and Management, Cost, Payment, and Delivery Reform, Health Equity, Health System Costs, Healthy Child Development, Maternal, Child, and Adolescent Health, Oral Health, Physical and Behavioral Health Integration, Population Health, Primary Care/Patient-Centered/Health Home, Safety Net Providers and Rural Health, Social Determinants of Health /by Amy ClaryFive years ago, Washington State launched a collaborative regional Accountable Communities of Health (ACH) model to improve the health of communities across the state. These ACHs have evolved into independent organizations that are integral to the state’s health system transformation efforts. A 2019 evaluation by the Center for Community Health and Evaluation found this ACH […]
Legislator Q&A: Colorado Enacts Nation’s First Insulin Cost Cap, Requires Attorney General to Investigate Prices
/in Policy Colorado Blogs, Featured News Home Chronic Disease Prevention and Management, Cost, Payment, and Delivery Reform, Health System Costs, Newly-Enacted Laws, Population Health, Prescription Drug Pricing, State Rx Legislative Action /by Sarah LanfordCan We Please Stop Fixating on Hospital Chargemasters?
/in Policy Blogs, Featured News Home Cost, Payment, and Delivery Reform, Health System Costs, Hospital/Health System Oversight /by Anya Rader Wallack, Deborah Fournier, Trish Riley and Marilyn BartlettCan States Really Produce Generic Drugs? The Civica Rx Model May Show the Way
/in Policy California Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyLast week, Gov. Gavin Newsom captured national attention when he announced California’s intention to produce its own generic drugs, building on earlier state efforts. Last year, the governor issued an executive order charging public payers to combine their purchasing power to negotiate better prices, and to eventually expand to include other payers in the state. […]
NASHP’s Top Five Reads of 2019
/in Policy Blogs, Featured News Home Administrative Actions, Chronic and Complex Populations, Chronic Disease Prevention and Management, Community Health Workers, Health Coverage and Access, Health System Costs, Legislative Tracker, Population Health, Prescription Drug Pricing, State Rx Legislative Action, Work Requirements, Workforce Capacity /by NASHP StaffEach year, NASHP publishes more than 100 reports and resources to give state leaders the information they need to craft effective legislation and health policies. Below are our most-read resources of 2019. Rx Legislative Tracker: This resource with its map interface gives you the status of every state’s legislation to curb prescription drug costs since 2015, […]
Slideshow: State Actions to Address Rising Prescription Drug Costs
/in Policy Featured News Home Administrative Actions, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by NASHP StaffSince 2017, the National Academy for State Health Policy has worked with states to develop and implement effective model policies to lower prescription drug prices. This slideshow highlights states’ administrative and legislative actions, including Medicaid innovations and more than 120 new laws that promote pharmacy benefit manager regulation, drug price transparency, wholesale drug importation from […]
Kentucky’s Public-Private Initiative Promotes Employment as a Critical Opioid Recovery Tool
/in Policy Kentucky Blogs, Featured News Home Behavioral/Mental Health and SUD, Chronic and Complex Populations, Chronic Disease Prevention and Management, Cost, Payment, and Delivery Reform, Health System Costs, Population Health, Social Determinants of Health /by NASHP Staff